美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
63539-502-30	63539-502	HUMAN PRESCRIPTION DRUG	XELJANZ XR	tofacitinib	TABLET, EXTENDED RELEASE	ORAL	20200121	N/A	NDA	NDA208246	U.S. Pharmaceuticals	TOFACITINIB CITRATE	22 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-502-30)
63539-501-30	63539-501	HUMAN PRESCRIPTION DRUG	XELJANZ XR	tofacitinib	TABLET, EXTENDED RELEASE	ORAL	20160307	N/A	NDA	NDA208246	U.S. Pharmaceuticals	TOFACITINIB CITRATE	11 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-501-30)
63539-501-14	63539-501	HUMAN PRESCRIPTION DRUG	XELJANZ XR	tofacitinib	TABLET, EXTENDED RELEASE	ORAL	20160307	N/A	NDA	NDA208246	U.S. Pharmaceuticals	TOFACITINIB CITRATE	11 mg/1	14 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-501-14)
0069-0501-30	0069-0501	HUMAN PRESCRIPTION DRUG	XELJANZ XR	tofacitinib	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160307	N/A	NDA	NDA208246	Pfizer Laboratories Div Pfizer Inc	TOFACITINIB CITRATE	11 mg/1	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0501-30)
0069-0502-30	0069-0502	HUMAN PRESCRIPTION DRUG	XELJANZ XR	tofacitinib	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200121	N/A	NDA	NDA208246	Pfizer Laboratories Div Pfizer Inc	TOFACITINIB CITRATE	22 mg/1	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0502-30)